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Abstract 
Background: Knowledge of the population genetics and transmission dynamics of Plasmodium vivax is crucial in 
predicting the emergence of drug resistance, relapse pattern and novel parasite phenotypes, all of which are relevant 
to the control of vivax infections. The aim of this study was to analyse changes in the genetic diversity of P. vivax genes 
from field isolates collected at different times along the Thai–Myanmar border.
Methods: Two hundred and fifty-four P. vivax isolates collected during two periods 10 years apart along the Thai–
Myanmar border were analysed. The parasites were genotyped by nested-PCR and PCR–RFLP targeting selected 
polymorphic loci of Pvmsp1, Pvmsp3α and Pvcsp genes.
Results: The total number of distinguishable allelic variants observed for Pvcsp, Pvmsp1, and Pvmsp3α was 17, 7 
and 3, respectively. High genetic diversity was observed for Pvcsp (HE = 0.846) and Pvmsp1 (HE = 0.709). Of the 254 
isolates, 4.3 and 14.6 % harboured mixed Pvmsp1 and Pvcsp genotypes with a mean multiplicity of infection (MOI) of 
1.06 and 1.15, respectively. The overall frequency of multiple genotypes was 16.9 %. When the frequencies of allelic 
variants of each gene during the two distinct periods were analysed, significant differences were noted for Pvmsp1 
(P = 0.018) and the Pvcsp (P = 0.033) allelic variants.
Conclusion: Despite the low malaria transmission levels in Thailand, P. vivax population exhibit a relatively high 
degree of genetic diversity along the Thai–Myanmar border of Thailand, in particular for Pvmsp1 and Pvcsp, with 
indication of geographic and temporal variation in frequencies for some variants. These results are of relevance to 
monitoring the emergence of drug resistance and to the elaboration of measures to control vivax malaria.
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Background
In Thailand, malaria is forest-related, with the highest 
prevalences recorded along regions bordering Myanmar, 
Laos and Cambodia. Forty-seven per cent of malaria 
cases in Thailand are due to Plasmodium vivax [1]. The 
control of P. vivax poses particular problems because of 
this parasite’s propensity to relapse. This is now com-
pounded by the emergence of drug resistance; recently, 
one case of chloroquine-resistant vivax malaria has been 
reported in Thailand [2]. Approximately 6  % of Thai 
patients treated with a short acting anti-malarial drug 
followed by primaquine suffer a relapse of vivax malaria 
within 28  days [3]. To date, knowledge of the biology 
and epidemiology of P. vivax is relatively limited. Epide-
miological and genetic studies of P. vivax population are 
essential for understanding the population dynamics and 
epidemiology of this parasite, and are relevant to moni-
toring responses to drug treatment.
Many polymorphic genetic markers are available for 
characterizing P. vivax populations [4–11]. Analyses of 
polymorphism and population diversity of P. vivax have 
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focused on parasite molecules that are under selection by 
host immunity [12–15]. Most targeted polymorphic loci 
are found on single-copy P. vivax genes: msp1 coding for 
merozoite surface proteins (MSP1) (Pvmsp1), msp3alpha 
coding for another merozoite surface protein (Pvmsp3α), 
and csp coding for circumsporozoite protein (CSP)(Pvcsp). 
Pvmsp1 gene has a mosaic structure, with seven con-
served blocks and six variable blocks [16]. Among these 
blocks, the variable block 10, previously designated as F3 
fragment, is highly polymorphic and as such is a suitable 
genetic marker for population studies [5, 7, 17]. Pvmsp3α 
is characterized by a distinct alanine-rich central region 
[18] with a high degree of polymorphisms [11, 19, 20]. The 
Pvcsp harbours a central immunodominant region with 
a variable number of tandem repeats represented by two 
major variant types, VK210 and VK247 [21, 22] with a 
worldwide distribution [23]. The three loci above are con-
sidered to be under selective immune pressure.
The current genetic data on P. vivax population lags 
behind those on P. falciparum. This study aims to assess 
the genetic diversity using Pvmsp1F3, Pvmsp3α and 
Pvcsp loci in P. vivax isolates collected along the Thai–
Myanmar border, and to investigate whether variations 
in frequencies occur geographically and temporally. This 
data is intended to help understand the dynamics of P. 




Two hundred and fifty-four stored anonymous frozen 
packed red cells collected during two periods: May 2003 
to August 2004 (n = 173) and March 2012 to March 2013 
(n = 81) were studied. DNA was extracted from the sam-
ples collected from patients presenting with P. vivax in Thai 
clinics along the Thai–Myanmar border in the west. The 
area is considered as having low and seasonal malaria trans-
mission. The annual malaria incidence rates along Greater 
Mekong Subregion were 0.13–10.15 to 6/1000 populations 
in 2008 [24]. However, based on the record, some of the 
infections were probably acquired in the bordering coun-
tries. These isolates were from patients with the mean age 
(mean ± SD) of 25.28 ± 7.8 (range 14–57) and the mean 
% parasitaemia of 0.32 (range 0.1–1.19) during 2003–2004; 
and of 29.8 ± 11.5 (range 15–58) and the mean % parasitae-
mia of 0.401 (range 0.1–1.67) during 2012–2013. This cross 
sectional retrospective study was approved by the Ethics 
Committee of the Faculty of Tropical Medicine, Mahidol 
University (Approval number: MUTM 2013-034-01).
DNA template preparation
Plasmodium vivax genomic DNA was extracted from 
200 µL of frozen-packed red cells using the commercially 
available DNA Blood kit according to the manufacturer’s 
instructions (QIAGEN, Germany). The volume of the 
template obtained was 100  µL, thus each 1  µL corre-
sponds to the DNA present in 2 µL of whole blood. Con-
firmation of the microscopic diagnosis examination was 
achieved by a multiplex real-time PCR assay using both 
genus- and species-specific primers [25].
Genotyping of Pvmsp1F3 and Pvmsp3α by Nested PCR
Previously described primers for Pvmsp1F3 and Pvmsp3α 
[7] were used to amplify the polymorphic loci by nested 
PCR, with some modification. Briefly, amplification reac-
tions were performed in a total volume of 25 µL contain-
ing 1X MyTag Red Mix (Bioline, UK) and 40 nM of each 
oligonucleotide primer. The amplification was initiated 
with 1 µL of the template genomic DNA, followed by 
the second amplification, in which 1 µL of diluted PCR 
products from the first amplification (at 1:1000 for Pvm-
sp1F3 and 1:100 for Pvmsp3α) were used. The cycling 
parameters were as follows: initial denaturation at 95 °C 
for 3 min; 30 cycles of denaturation at 95  °C for 1 min, 
followed by annealing at 60 °C for 1 min and extension at 
72 °C for 1 min, and a final extension at 72 °C for 5 min. 
All PCR products were then analysed by electrophoresis 
on 3  % agarose gels and visualized under UV illumina-
tion after staining with ethidium bromide. The size of the 
amplified fragments was estimated by comparison to a 
100  bp ladder marker. Each PCR product was screened 
for polymorphic banding by GeneTools analysis software 
(Syngene, UK). The genetic diversity of each marker was 
analysed by the number of alleles and the expected vir-
tual heterozygosity (HE), The expected virtual heterozy-
gosity (HE), defining as the probability that a randomly 
chosen pair of alleles differed from each other can range 
between 0 and 1, with values close to 1, reflecting high 
genetic diversity levels in a population [7]. The formula of 
expected heterozygosity (HE) is [n/(n − 1)] × (1 − ∑pi2), 
where “n” is the number of samples analysed and Pi is the 
proportion of the parasite population having allele i. The 
mean multiplicity of infection (MOI) was calculated by 
dividing the total number of P. vivax clones by the num-
ber of PCR-positive isolates [7].
Genotyping of Pvcsp by PCR–RFLP
Pvcsp genotyping was based on restriction fragment 
length polymorphism analysis of the PCR products 
(PCR–RFLP) [5]. Briefly, Pvcsp was amplified by nested-
PCR assay in a total of 25 µL and in presence of a reaction 
master mix containing 1X MyTag Red Mix (Bioline, UK) 
and 40  nM of each primer. One microlitres of template 
DNA was used to initiate amplification, followed by a sec-
ond amplification, in which 1 µL of PCR products from 
the first amplification was used. The cycling conditions 
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were as follows: 1 cycle of 95 °C for 5 min, 25 cycles (first 
amplification) and 30 cycles (second amplification) of 
denaturation at 94 °C for 1 min, followed by annealing at 
62 °C for 2 min and extension at 72 °C for 2 min, and final 
extension at 72 °C for 5 min. Subsequently, 20 µL of the 
second PCR products were separately digested by restric-
tion enzymes AluI and BstNI (New England Biolabs Inc., 
UK) according to the manufacture specification for 2 h in 
a total volume of 30 µL. The DNA fragments were sepa-
rated by electrophoresis on 3 % agarose gel and visualized 
under UV illumination after ethidium bromide staining.
Statistical analysis
Statistical analyses were performed using SPSS software 
version 15.0. The frequencies of allelic variants in each 
marker between two different periods of sample collec-
tion were analysed using Chi square or Fisher’s exact test 
as appropriate. The P value was estimated by Monte Carlo 
based on the number of 10,000 randomly sampled data sets. 
P value of < 0.05 were considered as statistically significant.
Results
Genetic diversity and multiplicity of Pvmsp1F3, Pvmsp3α 
and Pvcsp
Amplification of the Pvmsp1F3 and Pvcsp fragments 
was achieved successfully for all the 254 P. vivax isolates, 
whereas the Pvmsp3α fragment could not be amplified in 
45 isolates (18 %) despite repeated attempts (Table 1). The 
PCR fragments obtained were divided into bins that dif-
fered by 20 bp. Seven distinguishable Pvmsp1F3 size vari-
ants (designated A to G) with a size range of 220–360 bp 
(Fig. 1a) were observed with one variant (C, 251–270 bp) 
predominant at a frequency of 44  %. Three allelic size 
variants (designated A to C, 450–510 bp) were observed 
for the Pvmsp3α (Fig.  1b) at frequencies of 19, 34, and 
47 %, respectively. Nine size variants (designated A to I, 
range 503–760  bp) were noted for Pvcsp (Fig.  1c) with 
the predominant variant (D, 641–660 bp) found at a fre-
quency of 27 %. Pvcsp was further genotyped by RFLP [5] 
to distinguish between the two VK210 and VK247 repeat 
types (Fig. 2). When the PCR fragments are grouped by 
size and by repeat types, these could be divided into 17 
different allelic forms, 9 PCR size variants for VK210 type 
and 8 for VK247 type (Fig. 3). The highest frequency was 
found for VK210D in both collection periods.
The multiplicity of infection (MOI) and the expected 
virtual heterozygosity (HE) for Pvmsp1F3, Pvmsp3α 
and Pvcsp are shown in Table  1. High genetic diver-
sity was observed in Pvmsp1F3 (HE =  0.709) and Pvcsp 
(HE = 0.846). Mixed genotype infections were observed 
in Pvmsp1F3 (n = 11, 7 MOI of 2 and 4 MOI of 3) and in 
Pvcsp (n = 37, 36 MOI of 2 and 1 MOI of 3) with a mean 
MOI of 1.06 and 1.15, respectively.
Table 1 Genetic diversity for  Pvmsp1F3, Pvmsp3α 
and Pvcsp in the P. vivax isolates
a The multiplicity of infection (MOI) was calculated by dividing the total number 
of P. vivax clones by the number of PCR-positive isolates; HE, the expected 
virtual heterozygosity (the chance of drawing a pair of alleles differs from each 
other) using the following formula: HE = [n/(n − 1)] × (1 − ∑pi2), where pi is the 
frequency of the ith allele and n is the number of isolates analysed
Pvmsp1F3 Pvmsp3α Pvcsp
No. of alleles 7 3 9
No. of clones 269 209 292
No. of PCR positive isolates (%) 254 (100) 209 (82) 254 (100)
MOIa 1.06 1.00 1.15
HE
a 0.709 0.631 0.846
Fig. 1 Fragment size ranges for Pvmsp1F3, Pvmsp3α and Pvcsp genes 
in P. vivax isolates from Thailand. Gel electrophoresis of PCR products: 
a Pvmsp1F3, b Pvmsp3α (B), c Pvcsp. The variants were coded alpha-
betically starting from the smallest size. A 100 bp ladder was used as 
molecular weight marker (M)
Fig. 2 RFLP analysis of the Pvcsp fragments. In lanes with odd num-
bers, the fragments were digested with AluI (an enzyme that cuts 
repeatedly in the VK210 repeat region). In lanes with even numbers, the 
fragments were digested with BstNI (an enzyme that cuts repeatedly 
in the VK247 repeat region). Paired digestions from the fragments 
obtained from a single isolate are presented in lanes 1–2 (a VK210 
variant), lanes 3–4 (a VK247 variant), and in lanes 5–6 and 7–8 in which 
mixed genotypes are present. A 100 bp ladder was used as molecular 
weight marker (M)
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Distribution of allelic variants among P. vivax isolates 
along Thai–Myanmar border at different periods
The Pvmsp1F3 genotypes found in P. vivax isolates col-
lected over two periods from the Thai–Myanmar border 
were compared (Fig.  4). Seven allelic Pvmsp1F3 variants 
were observed with low frequencies of the A and G vari-
ants. Infection with the C variant was predominant among 
isolates (44 %), and for both collection periods that were 
separated by ten years (38 % during 2002–2003 and 56 % 
during 2012–2013). A significant difference in the fre-
quencies of the Pvmsp1F3 genotypes was found between 
the two collection periods (Fisher’s exact test, P = 0.018).
All three Pvmsp3α allelic variants were observed in the 
isolates from this area (Fig. 5). Infections with the C vari-
ant were predominant among the isolates (47 %), and for 
both collection periods (46  % for 2002–2003, and 48  % 
for 2012–2013). No significant differences in Pvmsp3α 
genotype frequencies were noted for the isolates col-
lected during the two collection periods (X2  =  0.701, 
degrees of freedom (df ) = 2, P = 0.724).
All 17 Pvcsp allelic variants (9 VK210 and 8 VK247) 
were found among the isolates collected. The distribu-
tion of single and mixed genotype infections of Pvcsp 
repeat types (VK210 and VK247) during two periods of 
10 years different are shown in Fig. 6. Mixed Pvcsp geno-
type infections, either different allelic variants or differ-
ent Pvcsp repeat types, were found among isolates with 
Fig. 3 Frequency distribution of Pvcsp allelic variants from Thai P. 
vivax isolates collected over two periods. The number of isolates in 
the period of 2003–2004 (n = 173) and of 2012–2013 (n = 81) were 
analysed. Seventeen allelic variants were defined according to size (A 
to I) and repeat types (VK210 and VK247)
Fig. 4 Distribution of Pvmsp1F3 allelic variants in P. vivax isolates 
collected along the Thai–Myanmar border during two periods. 
Distribution in 2003–2004 (black bars, n1 = number of isolates) and 
2012–2013 (white bars, n2 = number of isolates) were shown. The 
allelic variants were designated A to G. Significant differences in allelic 
variant frequency between the two collection periods are indicated 
by asterisk (Fisher’s exact test, P = 0.018)
Fig. 5 Distribution of Pvmsp3α allelic variants in P. vivax isolates 
collected along the Thai–Myanmar border during two periods. 
Distribution in 2003–2004 (black bars, n1 = number of isolates) and 
2012–2013 (white bars, n2 = number of isolates) were shown. The 
allelic variants were designated A to C. Chi square test did not detect 
any significant difference in allelic variant frequencies between the 
two collection periods (X2 = 0.701, degrees of freedom (df ) = 2, 
P = 0.724)
Fig. 6 Distribution of single and mixed genotype infections of the 
Pvcsp repeat types (VK210 and VK247) in P. vivax isolates collected 
along the Thai–Myanmar border. Distribution in the period of 
2003–2004 (black bars, n1 = number of isolates) and of 2012–2013 
(white bars, n2 = number of isolates) were shown. Significant dif-
ferences in allelic variant frequencies between the two collection 
periods are indicated by asterisk (X2 = 6.879, degrees of freedom 
(df ) = 2, P = 0.033)
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similar frequencies in both periods of sample collec-
tion (19  % during 2003–2004; 15  % during 2012–2013). 
VK210-only infections were predominant among isolates 
(66 %), and for both collection periods (69 % for 2002–
2003, and 59 % for 2012–2013). Significant difference in 
frequencies of single and mixed Pvcsp genotype infec-
tions between the two periods was found (X2  =  6.879, 
degree of freedom (df ) =  2, P =  0.033). The frequency 
of VK210-single infection was slightly lower, but VK247-
single infection was higher among isolates during 2012-
2013 (VK210, 59  %; VK247, 26  %) than those during 
2003–2004 (VK210, 69 %; VK247, 13 %).
Discussion
It has long been known that the morphologically similar 
parasites of a Plasmodium species are in fact biologically 
and immunologically highly diverse. Until the advent of 
molecular genotyping through amplification, the study 
of this diversity for the parasites of humans was limited 
to experimental infections, enzyme typing, differential 
reactivity to specific antibodies, and, for P. falciparum, 
to in  vitro cultured material. The advent of molecular 
genotyping based on genetic amplification has not only 
widened investigations to large numbers of field samples, 
but also to the all parasite species, including the hitherto 
neglected P. vivax.
The purpose of this study was to assess the genetic 
diversity of P. vivax collected from patients presenting 
in the Thai–Myanmar border of Thailand, for which a 
collection of samples obtained 10 years apart were avail-
able and based on the increasing evidence of drug resist-
ance in this border area by the report in 2002–2003 of 
chloroquine resistance in P. vivax in Dawei (Mon State), 
Myanmar [26]. Given that P. vivax infections are gener-
ally treated with chloroquine, an emergence in 2008 of P. 
vivax resistance to chloroquine in this border area was 
reported and their spread has probably contributed to 
maintain a higher than expected level of genetic diversity 
[2].
Three polymorphic loci commonly used for the study 
of P. vivax were used for this study: the repeat region of 
Pvcsp, the F3 fragment of Pvmsp1F3 and a segment of 
Pvmsp3α, which were evaluated by the number of dis-
tinguishable size allelic variants found in P. vivax iso-
lates. The data obtained for the Pvmsp1F3 and Pvcsp 
loci revealed that the parasites displayed a degree of 
genetic diversity with a high proportion of mixed geno-
type infections, which are in line with previous findings 
on the genetic diversity of P. vivax isolates collected from 
diverse endemic areas of Thailand [5, 9]. Recently, by 
using different sets of highly polymorphic microsatellite 
markers, a number of studies of genetic variability and 
transmission dynamics of P. vivax isolates from different 
malaria endemic areas have been observed with similar 
degree of diversity in Brazil (HE = 0.71) (HE = 0.71) [27]; 
Sri Lanka (HE  =  0.86)/Myanmar (HE  =  0.85)/Ethiopia 
(HE = 0.75) [28], and Vietnam (HE = 0.85) [29]. Moreo-
ver, some differences in the frequencies of Pvmsp1F3 
variants and Pvcsp repeat types were noted among iso-
lates in this border collected over the two distinct sample 
collection periods. Parasites with the Pvcsp VK210 repeat 
type dominated in all the samples sets analysed, a feature 
noted in other studies of isolates collected in Thailand [5, 
9], Myanmar (98 %) [30], India (99 %) [6], Guyana (92 %) 
[31], Pakistan (96 %) and Iran (69 %) [8]. In the present 
study, VK247-single infection was higher among isolates 
collected during 2012–2013 (25  %) than those during 
2003–2004 (13 %), with obviously higher in VK247G dur-
ing 2012–2013 (14 %). This striking increasing incidence 
might cause by several selective constraints imposed by 
drug usage [32], as well as local vectors [33]. It is well 
documented from previous studies in different drug sus-
ceptibility between P. vivax VK247 subtype and VK210 
subtype, in which the mean time to clear parasite DNA, 
as determined by quantitative PCR of P. vivax genotype-
specific DNA during a treatment course, was significantly 
slower for VK210 parasites than for VK247 parasites [32]. 
Likewise, the differential susceptibility of mosquito vec-
tors to P. vivax circumsporozoite phenotypes in south-
ern Mexico was found, in which Anopheles albimanus 
is more susceptible to VK210 carrying parasites while 
Anopheles pseudopunctipennis is more susceptible to 
VK247 carrying parasites [33].
The Pvmsp3α fragment amplified in this study was 
relatively uninformative in that only three allelic variants 
were detected. In a previous study of P. vivax from Papua 
New Guinea employing the same amplification protocol, 
a high degree of diversity was observed, with 15 distinct 
allelic variants detected in 106 samples [7]. The contrast 
with the low diversity observed in this study is probably 
due to use of classical gel electrophoresis with a relatively 
low resolution (bin sizes of 20  bp) rather than capillary 
electrophoresis (bin sizes of 3 bp). This has also probably 
contributed to underestimate the diversity of Pvmsp1F3, 
since 28 distinct allelic variants were observed using cap-
illary electrophoresis for the P. vivax isolates from Papua 
New Guinea [7]. It should be noted that genetic diversity 
is likely to be higher in Papua New Guinea where the 
malaria endemicity is higher than that on the Thai bor-
ders. Nonetheless, comparison of parasite genotyping 
data from different studies should be interpreted in the 
light of the resolution of the method used to distinguish 
between allelic variants. Sequencing of the allelic variants 
present in each would provide the most accurate data for 
genetic diversity studies; however, cost considerations 
preclude this for a number of researchers in endemic 
Page 6 of 8Maneerattanasak et al. Malar J  (2016) 15:75 
areas. Moreover, data from the standard protocols that 
are accessible to most is generally sufficient to provide 
a clear broad picture of parasite genetic diversity and to 
decide whether further more detailed studies would be 
warranted.
Whereas analyses of P. falciparum populations indi-
cate that the MOI is broadly correlated with transmission 
levels [34–36], the observed MOI values for the Thai P. 
vivax isolates presented here were high despite the low 
levels of malaria transmission. This might indicate that 
the transmission levels are underestimated. It is prob-
able that the presence of hypnozoites, which are the liver 
dormant forms that can activate at various times in the 
months and years following the infectious bite to initi-
ate a blood infection, contributes significantly to this 
high level of diversity. P. vivax strains in Southeast Asia 
region are predicted to have a high relapse incidence (836 
relapses per 100,000 person days) and a rapid mean time 
from primary episode to first relapse (41 days) [37]. Fur-
thermore, analyses of relapse parasites clearly indicated 
that they are genetically diverse and often distinct from 
the parasites that appear during the primary infection 
[38, 39]. Another potential explanation is the geographi-
cal location of the site where the survey presented here 
was conducted. The proximity to the border of Myanmar 
where malaria endemicity is higher than in Thailand has 
probably contributed to increase diversity through the 
frequent movement of populations to and from Thailand, 
resulting in a steady introduction of strains. In the course 
of this study, a few P. vivax isolates were also collected 
at the Thai–Thai–Lao border (n = 1 during 2003–2004, 
and n  =  10 during 2012–2013) and the Thai–Cambo-
dia border (n = 3 during 2003–2004, and n = 10 during 
2012–2013). Despite the limited number of isolates, they 
were found to harbour numerous distinct allelic variants 
for the three markers (five variants for Pvmsp1F3, three-
variants for Pvmsp3α, and seven variants for Pvcsp, and 
three isolates had mixed Pvcsp genotype infections for 
the Thai–Lao boder; and six variants for Pvmsp1F3, three 
variants for Pvmsp3α, and 10 variants for Pvcsp and four 
isolates had mixed genotype infections at the Thai–Cam-
bodia border). This might be due to the fact that P. vivax 
infections are generally treated with chloroquine, there-
fore, the emergence in 2008 of P. vivax resistance to chlo-
roquine in areas of Myanmar bordering Thailand [26], 
and their spread has probably contributed to maintain a 
higher than expected level of genetic diversity [2].
Multiple genotype infections are common in malaria, 
and higher multiplicities of infections are likely to facili-
tate genetic recombination of parasites leading to the 
generation of novel strains [40], and could be an indica-
tor of immune status [41]. Previous studies indicated 
that allelic recombination events are associated with 
the genetic diversity of Pvmsp1F3 [8, 16], Pvmsp3α [11, 
20] and Pvcsp [10]. Mixed genotype Pvmsp1F3 or Pvcsp 
infections were found in 17 % of the isolates, a frequency 
similar to that observed in previous surveys in Thailand 
[5, 9], in India using Pvmsp3α [6], in Papua New Guinea 
using Pvmsp1F3 [42], or in Pakistan and Iran using 
Pvmsp1 [8]. Knowledge of the genetic diversity can be 
used to assess geographical differentiation and explain 
the spatial distribution of alleles at a given loci, and pro-
vide a baseline information for surveillance systems 
directed to identifying the origin of isolates in areas with 
occasional imported malaria cases [40].
The extensive polymorphism that characterize the loci 
targeted in this study are considered to be the result of 
selective constraints to which P. vivax is subjected [43], 
which include immune responses in the vertebrate host 
[39], drug pressure [32], as well as vector competence 
[33]. In this study, the degree of diversity recorded for 
the three markers did not vary between two collection 
that were separated by 10 years, though the frequencies 
of some Pvmsp1F3 and Pvcsp allelic variants altered sig-
nificantly with time. Given the relatively limited num-
ber of isolates analysed and for each period, it is unclear 
whether these variations are sotchastic or due to selective 
pressure.
Conclusion
In summary, this study demonstrated that high genetic 
diversity and multiplicity of infection levels occur in the 
P. vivax parasites circulating along the Thai–Myanmar 
border despite the low level of malaria transmission to 
which the resident populations are subjected. The geno-
typing data presented will be useful to the selection of 
markers suitable for use in drug efficacy studies, and to 
an improved understanding of the epidemiology of P. 
vivax in Thailand, which can guide the design of meas-
ures to control and eventually eliminate this parasite.
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